Results 151 to 160 of about 6,749,359 (294)
MIMAP on Health, Nutrition and Education [PDF]
This paper describes a framework for analyzing the micro-level impacts of macroeconomic adjustment policies on health, nutrition and education. The development of the framework has drawn heavily on the existing body of economic theory and the insights ...
Herrin, Alejandro N.
core
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
Healthy school-age kids (HSAK) program [PDF]
The Healthy School-Age Kids (HSAK) program is a joint initiative of the Department of Health and Community Services and the Department of Employment, Education and Training and it works within the health promoting school model. It recognises the need for
core
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor +2 more
wiley +1 more source
Injury and violence: undertaught and overdue in public health education. [PDF]
Schreiner C +3 more
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
Completing the Continuum of Public Health Education. [PDF]
Riegelman RK.
europepmc +1 more source

